1Marit G. Treatment of relapsed or refractory acute leukencia: comparison of two different regimens[J]. Hematol and Blood Transfusion, 1990,33: 614.
2Broxterman H J, Sonneveld P, Pieters R, et al. Do Pglycoprotein and Majoy Vault Protein(MVP/TRP) expression correlate with in vitro daunornbicin resistame in acute myeloid leukemia? [J].Leukemia, 1999,13 (2): 258.
5Cassileth PA, Harrington DP, Appelbaum FR, et al. Chemotherapy compared with autologous or allogenic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med, 1998, 339: 1649-1656.
7Bow E J, Kilpatrick MG, Scott BA, et al. Acute myeloid leukemia in Manitoba: The consequences of standard "7+3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome. Cancer, 1994, 74: 52-60.
